Amelita Tîrnăveanu *, A. Lenghel *, B. Cuparencu **, I. Pușcaș ***
* Dr. Tîrnăveanu Amelita – asistent universitar medicină internă, medic rezident gastroenterologie an IV, doctorand, Spital Clinic Județean, Clinica Medicală IV, Oradea
* Conf. Dr. A. Lenghel – Spital Clinic județean, Clinica Medicală IV,·Oradea
** Prof. Univ. Dr. Doc. B. Cuparencu – Catedra de Farmacologie, Facultatea de Medicină Oradea
*** Prof. Univ. Dr. Doc. I. Pușcaș, Universitatea Oradea, Centrul de Cercetări al Academiei
Șimleul-Silvaniei
Abstract
Calcithonin inhibits bazal and stimulated gastric acid output (with pentagastrin and insulin) both in witnesses and in patients with duodenal ulcer. Maximal inhibitor effect (inhibition) occurs at 2 hours after calcithonin administration. Endogenous gastrinemia increases, but not in a signifiant manner, after calcithonin administration.